Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 37% ± 18% | |
peripheral blood | 8 studies | 32% ± 16% | |
eye | 8 studies | 36% ± 17% | |
intestine | 7 studies | 30% ± 15% | |
uterus | 5 studies | 57% ± 23% | |
adipose | 5 studies | 18% ± 3% | |
kidney | 4 studies | 29% ± 14% | |
placenta | 4 studies | 40% ± 14% | |
heart | 4 studies | 25% ± 3% | |
esophagus | 4 studies | 44% ± 23% | |
breast | 4 studies | 53% ± 23% | |
prostate | 4 studies | 69% ± 27% | |
lymph node | 3 studies | 29% ± 11% | |
bone marrow | 3 studies | 28% ± 8% | |
skin | 3 studies | 54% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 13594.34 | 180 / 180 | 100% | 91.08 | 430 / 430 |
esophagus | 100% | 24195.59 | 1444 / 1445 | 100% | 124.43 | 183 / 183 |
prostate | 100% | 18130.58 | 245 / 245 | 100% | 69.56 | 500 / 502 |
uterus | 100% | 15123.19 | 170 / 170 | 99% | 123.55 | 456 / 459 |
lung | 99% | 20531.85 | 575 / 578 | 99% | 98.71 | 1147 / 1155 |
bladder | 100% | 21896.00 | 21 / 21 | 98% | 89.25 | 496 / 504 |
thymus | 99% | 14025.41 | 646 / 653 | 99% | 63.87 | 599 / 605 |
intestine | 98% | 17155.27 | 943 / 966 | 100% | 66.15 | 525 / 527 |
kidney | 94% | 11784.66 | 84 / 89 | 99% | 99.92 | 890 / 901 |
pancreas | 97% | 15440.00 | 318 / 328 | 96% | 71.73 | 171 / 178 |
skin | 100% | 28224.62 | 1808 / 1809 | 92% | 63.78 | 434 / 472 |
breast | 100% | 20976.68 | 459 / 459 | 87% | 50.13 | 976 / 1118 |
stomach | 82% | 11566.04 | 294 / 359 | 99% | 61.36 | 284 / 286 |
adrenal gland | 92% | 8795.81 | 237 / 258 | 48% | 20.80 | 110 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 65.25 | 80 / 80 |
muscle | 100% | 279203.41 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 142.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.44 | 1 / 1 |
blood vessel | 100% | 24410.26 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 23299.35 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 26588.55 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 16803.59 | 891 / 929 | 0% | 0 | 0 / 0 |
spleen | 93% | 7654.89 | 223 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 32.58 | 25 / 29 |
brain | 11% | 805.03 | 303 / 2642 | 60% | 21.03 | 421 / 705 |
liver | 16% | 1326.34 | 37 / 226 | 26% | 11.71 | 107 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048642 | Biological process | negative regulation of skeletal muscle tissue development |
GO_0010468 | Biological process | regulation of gene expression |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_0007283 | Biological process | spermatogenesis |
GO_0001701 | Biological process | in utero embryonic development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0009566 | Biological process | fertilization |
GO_0060546 | Biological process | negative regulation of necroptotic process |
GO_2000242 | Biological process | negative regulation of reproductive process |
GO_0008584 | Biological process | male gonad development |
GO_0006915 | Biological process | apoptotic process |
GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
GO_1902219 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress |
GO_0071474 | Biological process | cellular hyperosmotic response |
GO_0046622 | Biological process | positive regulation of organ growth |
GO_0035234 | Biological process | ectopic germ cell programmed cell death |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005634 | Cellular component | nucleus |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YBX3 |
Protein name | Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB) Y-box binding protein 3 |
Synonyms | CSDA DBPA |
Description | FUNCTION: Binds to the GM-CSF promoter. Seems to act as a repressor. Binds also to full-length mRNA and to short RNA sequences containing the consensus site 5'-UCCAUCA-3'. May have a role in translation repression (By similarity). . |
Accessions | ENST00000544622.4 ENST00000279550.11 [P16989-2] P16989 A0A0D9SEI8 ENST00000228251.9 [P16989-1] |